Sánchez-Lozada · Nephron. Experimental nephrology 2012 · in vitro and animal experimental study · n=?

Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations.

Cited 354 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical laboratory study using cultured human cells and a rat model

PubMed 23235493 · doi:10.1159/000345509 · record verified 2026-08-27

What was done

Researchers evaluated the effect of soluble uric acid on mitochondrial function in cultured human aortic endothelial cells by measuring oxidative stress, nitric oxide, mitochondrial density, ATP production, aconitase-2 and enoyl Co-A hydratase-1 expressions, and aconitase-2 activity in isolated mitochondria. They also assessed renal mitochondrial integrity (mitochondrial DNA damage, intrarenal uric acid, and oxidative stress) in rats with hyperuricemia induced by uricase inhibition.

What was found

The abstract reports no numerical values, concentrations, or statistical metrics. Qualitatively, uric acid exposure in endothelial cells was associated with reduced mitochondrial mass, decreased ATP production, reduced aconitase-2 activity, and lowered enoyl CoA hydratase-1 expression. In hyperuricemic rats, increased intrarenal uric acid and oxidative stress were associated with increased renal mitochondrial DNA damage.

Why it matters

This study provides mechanistic evidence that uric acid impairs endothelial function via mitochondrial alteration and ATP depletion, suggesting a biological pathway connecting hyperuricemia to vascular disease and hypertension.

Limits

Findings are limited entirely to in vitro cell culture and a rodent model, lacking direct human clinical data. The abstract provides no quantitative data, sample sizes, exposure doses or durations, or statistical confidence intervals.

Cited by